Table 3.
Lifestyle-related and preoperative clinical factors in Group NBNC according to alcohol consumption.
| NALP (n = 30) | ALP (n = 46) | P value | |
|---|---|---|---|
| Age (years) | 73.3 ± 6.3 | 69.7 ± 10.9 | 0.491 |
| Gender (Male/Female) | 22/8 | 45/1 | 0.001 |
| Obesity | 7 (23.3%) | 8 (17.4%) | 0.525 |
| Hypertension | 13 (43.3%) | 23 (50.0%) | 0.569 |
| DM | 11 (36.7%) | 16 (34.8%) | 0.867 |
| Cigarette smoking | 13 (43.3%) | 34 (73.9%) | 0.007 |
| Albumin (g/dL) | 3.7 (2.5–5.0) | 3.9 (2.8–4.6) | 0.658 |
| Total Bilirubin (mg/dL) | 0.5 (0.2–1.3) | 0.5 (0.2–0.9) | 0.834 |
| Platelet count (×104/mm3) | 20.8 (8.0–40.4) | 17.8 (6.7–51.6) | 0.100 |
| NLR | 2.12 (0.87–12.80) | 2.15 (0.79–7.43) | 0.461 |
| PT (%) | 93.0 (54.8–131.4) | 100.5 (63.4–131.4) | 0.714 |
| ICG R15 (%) | 11.4 (0.3–29.0) | 9.9 (1.6–31.5) | 0.124 |
| AFP (ng/mL) | 7.0 (1–48157) | 5.0 (1–7153) | 0.398 |
| DCP (mAU/mL) | 94.0 (14–85330) | 80.0 (11–15387) | 0.741 |
| Child-Pugh B/C | 3 (10.0%) | 3 (6.5%) | 0.583 |
| Multiple tumors | 10 (33.3%) | 12 (26.1%) | 0.496 |
| Tumor size (cm) | 5.0 (1.0–15.0) | 3.8 (1.2–17.0) | 0.229 |
| ≧10 cm | 6 (20.0%) | 8 (17.4%) | 0.774 |
| BCLC stage B/C | 9 (30.0%) | 9 (19.6%) | 0.296 |
| Beyond Milan criteria | 19 (63.3%) | 19 (41.3%) | 0.060 |
| Preoperative TACE | 15 (50.0%) | 27 (58.7%) | 0.456 |
NALP: non-alcoholic patients; ALP: alcoholic patients; DM: diabetes mellitus; NLR: neutrophil-to-lymphocyte ratio; PT: prothrombin time; ICG R15: indocyanine green retention rate at 15 minutes; AFP: serum α-fetoprotein; DCP: des-r-carboxyprothrombin; BCLC: Barcelona Clinic Liver Cancer; TACE: transcatheter arterial chemoembolization.